Internal Medicine, Nephrology · Chillicothe, OH
NPI
1861629420
Since 2009
Specialty
Internal Medicine, Nephrology
Code 207RN0300X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
4439 State Route 159
Chillicothe, OH, 45601
Phone (740) 779-8728
Groups this clinician bills Medicare through
Medicare paid, 2024
$138K
2,238 services
Medicare patients, 2024
574
Average age 74
Drug cost, 2024
$1.5M
4,530 prescriptions
Company payments, 2025
$359
From 9 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Kevin M Pargeter was code G2211 (visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's), 615 times for 342 patients. In total Kevin M Pargeter billed 2,238 services in 21 codes, and Medicare paid $138K.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2020-12-15.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|---|---|---|---|---|
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Facility | 615 | 342 | $10.96 | $6,742 |
| 99214 Office E&M - Established | Facility | 558 | 328 | $63.55 | $35K |
| 99233 Hospital E&M - Subsequent | Facility | 209 | 71 | $85.89 | $18K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 139 | 97 | $10.98 | $1,526 |
| 99214 Office E&M - Established | Office | 123 | 89 | $66.92 | $8,231 |
| 99215 Office E&M - Established | Facility | 97 | 75 | $98.12 | $9,517 |
| 90960 ESRD Related Services (not dialysis) | Office | 76 | 43 | $263.00 | $20K |
| 99213 Office E&M - Established | Facility | 65 | 56 | $43.29 | $2,814 |
| 99222 Hospital E&M - Initial | Facility | 58 | 52 | $95.93 | $5,564 |
| 99232 Hospital E&M - Subsequent | Facility | 50 | 26 | $57.81 | $2,891 |
| 90935 Hemodialysis | Office | 43 | 11 | $52.77 | $2,269 |
| 90961 ESRD Related Services (not dialysis) | Office | 43 | 30 | $209.79 | $9,021 |
| 99215 Office E&M - Established | Office | 25 | 23 | $116.81 | $2,920 |
| 90935 Hemodialysis | Facility | 22 | 17 | $48.75 | $1,072 |
| 99204 Office E&M - New | Facility | 22 | 22 | $91.14 | $2,005 |
By year: 2022 $157K for 1,689 services; 2023 $146K for 1,545 services; 2024 $138K for 2,238 services.
Medicare prescription drug claims, 2024
In 2024, the drug Kevin M Pargeter prescribed most often to Medicare patients was Kerendia (Finerenone), with 609 prescriptions and refills. In total Kevin M Pargeter wrote 4,530 Medicare prescriptions that cost $1.5M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Kerendia Finerenone | 609 | 783 | 106 | $496K |
| Farxiga Dapagliflozin Propanediol | 440 | 656 | 98 | $362K |
| Calcitriol Generic | 382 | 909 | 107 | $5,151 |
| Furosemide Generic | 304 | 614 | 84 | $1,183 |
| Losartan Potassium Generic | 295 | 756 | 100 | $2,270 |
| Lisinopril Generic | 222 | 575 | 75 | $1,225 |
| Amlodipine Besylate Generic | 191 | 506 | 58 | $1,130 |
| Potassium Chloride Generic | 168 | 338 | 41 | $3,748 |
| Jardiance Empagliflozin | 141 | 177 | 32 | $101K |
| Allopurinol Generic | 137 | 375 | 48 | $977 |
| Carvedilol Generic | 131 | 314 | 39 | $705 |
| Spironolactone Generic | 119 | 268 | 32 | $1,292 |
| Chlorthalidone Generic | 118 | 253 | 32 | $1,684 |
| Tamsulosin Hcl Generic | 109 | 249 | 29 | $1,142 |
| Hydralazine Hcl Generic | 98 | 221 | 29 | $1,402 |
Brand drugs: 1,439 claims; generic drugs: 3,091 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Kevin M Pargeter $359 ($359 in general payments such as food, travel and fees) from 9 companies. The largest payer was Bayer Healthcare Pharmaceuticals Inc. with $161.
| Company | Payments | Amount |
|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 8 | $161 |
| Ardelyx, Inc. ARDX | 3 | $58.95 |
| Novo Nordisk Inc NVO | 2 | $44.22 |
| Novartis Pharmaceuticals Corporation NVS | 1 | $23.71 |
| Kyowa Kirin, Inc. 4151.T | 1 | $19.93 |
| Alexion Pharmaceuticals, Inc. AZN | 1 | $16.05 |
| AstraZeneca Pharmaceuticals LP AZN | 1 | $14.07 |
| Amgen Inc. AMGN | 1 | $13.65 |
| Travere Therapeutics, Inc. TVTX | 6 | $7.42 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.